Total Payments
$19,143
2024 Payments
$2,373
Companies
71
Transactions
1,031
Medicare Patients
749
Medicare Billing
$79,767
Payment Breakdown by Category
Food & Beverage$19,050 (99.5%)
Education$92.94 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,050 | 1,023 | 99.5% |
| Education | $92.94 | 8 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,291 | 117 | $0 (2024) |
| Gilead Sciences, Inc. | $2,690 | 116 | $0 (2024) |
| Novo Nordisk Inc | $2,134 | 142 | $0 (2024) |
| ViiV Healthcare Company | $1,521 | 81 | $0 (2024) |
| PFIZER INC. | $795.94 | 38 | $0 (2024) |
| Lilly USA, LLC | $765.53 | 52 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $631.73 | 32 | $0 (2021) |
| Amgen Inc. | $551.05 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $546.33 | 27 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $499.13 | 48 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,373 | 113 | ViiV Healthcare Company ($483.38) |
| 2023 | $2,049 | 104 | Gilead Sciences, Inc. ($324.35) |
| 2022 | $2,311 | 125 | Gilead Sciences, Inc. ($431.31) |
| 2021 | $2,404 | 144 | Gilead Sciences, Inc. ($435.28) |
| 2020 | $2,511 | 144 | AstraZeneca Pharmaceuticals LP ($380.52) |
| 2019 | $2,645 | 134 | AstraZeneca Pharmaceuticals LP ($520.53) |
| 2018 | $2,394 | 132 | AstraZeneca Pharmaceuticals LP ($410.37) |
| 2017 | $2,455 | 135 | AstraZeneca Pharmaceuticals LP ($733.66) |
All Payment Transactions
1,031 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 12/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: HIV | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: HIV | ||||||
| 11/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: NEUROLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: HIV | ||||||
| 11/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: HIV | ||||||
| 10/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Obesity | ||||||
| 10/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 10/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $23.13 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $77.99 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 194 | 251 | $33,290 | $21,852 |
| 2022 | 4 | 185 | 260 | $32,840 | $20,475 |
| 2021 | 5 | 181 | 239 | $29,385 | $21,232 |
| 2020 | 6 | 189 | 245 | $24,880 | $16,207 |
Total Patients
749
Total Services
995
Medicare Billing
$79,767
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 114 | $15,940 | $9,235 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $7,420 | $6,920 | 93.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 67 | $6,700 | $3,557 | 53.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $3,230 | $2,141 | 66.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 103 | $14,280 | $7,959 | 55.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $6,160 | $5,906 | 95.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 100 | $9,950 | $5,406 | 54.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $2,450 | $1,205 | 49.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 105 | $13,430 | $8,731 | 65.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 75 | $6,690 | $4,024 | 60.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $4,000 | $3,934 | 98.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $2,625 | $2,612 | 99.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 15 | $2,640 | $1,932 | 73.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 90 | $10,350 | $6,227 | 60.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 52 | 79 | $6,715 | $3,750 | 55.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 30 | 30 | $3,900 | $3,570 | 91.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 18 | 20 | $3,200 | $2,188 | 68.4% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 13 | 13 | $325.00 | $249.21 | 76.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $390.00 | $223.08 | 57.2% |
About Dr. Rolando Maldonado, MD
Dr. Rolando Maldonado, MD is a Family Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003856089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rolando Maldonado, MD has received a total of $19,143 in payments from pharmaceutical and medical device companies, with $2,373 received in 2024. These payments were reported across 1,031 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($19,050).
As a Medicare-enrolled provider, Maldonado has provided services to 749 Medicare beneficiaries, totaling 995 services with total Medicare billing of $79,767. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Houston, TX
- Active Since 06/07/2006
- Last Updated 02/03/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003856089
Products in Payments
- FARXIGA (Drug) $2,187
- Ozempic (Drug) $1,227
- JARDIANCE (Drug) $597.45
- APRETUDE (Biological) $541.74
- DOVATO (Drug) $507.60
- VRAYLAR (Drug) $507.54
- VYVANSE (Drug) $427.19
- BREZTRI (Drug) $359.91
- XIFAXAN (Drug) $350.43
- Repatha (Biological) $314.04
- MOUNJARO (Drug) $292.25
- TRELEGY ELLIPTA (Drug) $289.58
- Rybelsus (Drug) $288.48
- SOLIQUA (Drug) $273.09
- Victoza (Drug) $248.14
- APLENZIN (Drug) $243.70
- JANUVIA (Drug) $240.21
- COLOGUARD (Device) $235.82
- CABENUVA (Biological) $229.43
- AIRSUPRA (Drug) $226.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Houston
Shannon Schrader, Md, MD
Family Medicine — Payments: $383,042
Family Medicine $383,042
Dr. Eric Nolen, Md, Mba, MD, MBA
Family Medicine — Payments: $158,026
Family Medicine $158,026
Candice Winful, M.d, M.D
Family Medicine — Payments: $123,290
Family Medicine $123,290
Dr. Joe Pouzar, M.d, M.D
Family Medicine — Payments: $104,957
Family Medicine $104,957
Victor Escobar, M.d, M.D
Family Medicine — Payments: $79,840
Family Medicine $79,840
Dr. Oscar De Valle, M.d, M.D
Family Medicine — Payments: $78,226
Family Medicine $78,226